Edgewise Therapeutics to Participate in Upcoming Investor Conferences
Accessibility StatementSkip Navigation BOULDER, Colo., Nov. 7, 2025 /PRNewswire/ --Â Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will participate in the following investor conferences: Guggenheim 2nd Annual Healthcare Innovation Conference Fireside chat:Â Tuesday, November 11, 2025 at 8:30 am ET Piper Sandler 37th Annual Healthcare Conference Fireside chat:Â Tuesday, December 2, 2025 at 2 pm ET 8th Annual Evercore Healthcar ...